1H-Benzimidazole-5-carboxylic acid, 2-[4-[[4'-chloro-4-(2-oxo-1-pyrrolidinyl)[1,1'-biphenyl]-2-yl]methoxy]-2-fluorophenyl]-1-cyclohexyl-;2-[4-[2-(4-Chlorophenyl)-5-(2-oxopyrrolidin-1-yl)benzyloxy]-2-fluorophenyl]-1-cyclohexylbenzimidazol;JTK 109;JTK109;JTK-109;JTK-109, 10 mM in DMSO
JTK-109 is a potent inhibitor of hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, with an IC50 value of 0.017 μM; it is used in research on hepatitis C virus (HCV).